China Resources Pharmaceutical Group Limited provided earnings forecasts for the nine months ended 30 September 2022. For the nine months, the total operating income of Jiangzhong Pharmaceutical is expected to increase by approximately 45% year-on- year, and the net profit attributable to shareholders to increase by approximately 12% year-on-year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.96 CNY | -1.48% | -6.99% | +24.33% |
Apr. 26 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.33% | 2.27B | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- 600750 Stock
- News Jiang Zhong Pharmaceutical Co.,Ltd
- China Resources Pharmaceutical Group Limited Provides Earnings Forecasts for the Nine Months Ended 30 September 2022